Skip to content

Revati Shreeniwas, MD

NPI 1538295704ActiveIndividual· Internal Medicine, Pulmonary Disease· Stanford, CA

Internal Medicine, Pulmonary Disease (MD) in Stanford, California, licensed in CA, with an NPI issued in February 2007. Jazz Pharmaceuticals Inc. reported $26,600 in payments in 2025, mostly consulting fees.

Overview

NPI1538295704
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedFeb 24, 2007
Last updated in NPPESApr 4, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001XC50034CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$26,600 · 4 payments from 1 company
  • 2024$214,800 · 12 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Jazz Pharmaceuticals Inc.$26,6004

What the 2025 payments were for

  • Consulting Fee$26,600 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pulmonologists in Stanford

All 51 pulmonologists in Stanford · All pulmonologists in California